A Minnesota cardiology firm that develops transcatheter septal occluders to repair congenital heart defects in children and adults has raised $2.08 million, according to a regulatory filing. Cardia’s septal occluders, new innovative medical devices that are cardiac implants, repair a cardiac defect known as a “hole in the heart.” It appears that Cardia is the […]
The market for cardiac surgery devices was valued at $2 billion in 2010. That includes surgery related to heart valve problems that require mitral valve repair to treat patients who suffer mitral regurgitation. One Minnesota company wants to take a portion of the mitral valve repair market by commercializing a minimally invasive cardiac surgery device […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Cardiology medical device maker AtriCure (NASDAQ:ATRC) expects to receive U.S. regulatory clearance for a new cryoablation system by the end of next quarter. The company’s cryoICE BOX system would use extreme cold to freeze cardiac tissue in order to correct abnormal electrical signals that cause heart arrhythmia. The system was launched during the second quarter […]
Doing nothing is the hardest thing in the world for a doctor to do. After all, doctors are doers. That is how they have managed to achieve their degrees: hard work, discipline, perseverance. Who else would be willing to memorize all those organic chemistry equations long enough to vomit them back on paper? Who else […]
CORRECTED Eden Prairie, Minnesota-based cardiac medical device firm Sunshine Heart has raised Australian $4.6 million ($5.03 million) by selling 115 million shares in a private placement with institutional investors in the U.S. and Canada, the company announced Monday. Sunshine Heart is listed on the Australian stock exchange and investors in this round are buying shares […]
A medical device company focused on specific minimally invasive cardiac surgeries has moved from Boston to Cleveland hoping to collect $1.5 million and develop its product. Securus Medical Group is well on the way to closing that round. It received a $500,000 equity investment already, is expecting to close to another $250,000 and will likely […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
St. Jude Medical (NYSE:STJ) announced Thursday that it has received European regulatory clearance for its Ilumien system, a diagnostic tool for treating heart disease. The Minnesota maker of new innovative medical devices said the system is the world’s first and only diagnostic tool that integrates optical coherence tomography (OCT) and fractional flow reserve (FFR) technologies […]
Heart valve replacement device maker ValveXchange, a Cleveland Clinic spinoff, has received a $3.5 million equity investment from CryoLife (NYSE: CRY). The investment seems to have been a long time coming for Colorado-based ValveXchange, which was established in 2001 and deemed to be at the “pre-series A” stage on Cleveland Clinic Innovations’ (CCI) website. CCI […]
Word has it that Cleveland Clinic is gathering nominees from its staff for the best healthcare innovations of 2012: the Top 10 list that’s the cornerstone of the health system’s annual innovations summit. This year’s summit, which starts Oct. 3, will focus on cardiovascular technologies. But the list never focuses on one single technology. And […]
A drug-device combination bankrolled by Medtronic Inc. (NYSE:MDT) and developed by Nile Therapeutics Inc. (NSDQ:NLTX) completed dosing its first patient in Part B of an ongoing phase 1 study of cenderitide, a peptide treatment for heart failure. Medtronic funded the trial and provided expertise on building a drug-device combination to “assess the pharmacokinetics and phamacodynamics […]
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Noninvasive cardiac imaging company CardioInsight Technologies has added another $1 million ahead of an August product launch in Europe. The Cleveland-based developer of new innovative medical devices was awarded a $1 million loan from the state of Ohio that it will use to help commercialize its technology. CardioInsight expects to receive European regulatory clearance in […]
Cardiac medical device maker AtriCure (NASDAQ:ATRC) sees big opportunity in a new “hybrid” procedure that treats atrial fibrillation with a combination of ablation from inside and outside of the heart. But the Cincinnati-area company will likely have to wait awhile before it begins to cash in on what CEO David Drachman has called a $2 […]
CORRECTION: Due to inaccurate information provided, an earlier version of the story stated that the Valiant Thoracic Stent Graft System is available in the U.S and Europe. While it is approved domestically, it has yet to launch commercially. Medtronic Inc. (NYSE:MDT) reported positive clinical trial data on its Valiant Thoracic Stent Graft System at the one-year […]
Athersys (NASDAQ:ATHX) reported that results from a phase 1 trial of its stem cell therapy suggest its MultiStem technology could hold benefits for heart attack patients. The positive results from a one-year followup on the trial will pave the way for Cleveland-based Athersys to begin a phase 2 trial on heart attack patients later this […]
A phase 1 clinical trial has shown that Juventas Therapeutics‘ regenerative medicine therapy provides clinical benefit to heart failure patients. Phase 1 trials generally focus on safety, so the indication of clinical benefit is an encouraging sign for Cleveland-based Juventas. “We are excited to see strong signs of efficacy across multiple clinical parameters,” CEO Rahul […]